Northwestern University Feinberg School of Medicine

Prostate Cancer SPORE

Sarki Abdulkadir, MD, PhD

Maha Hussain, MD

The Robert H. Lurie Comprehensive Cancer Center of Northwestern University was awarded a five-year, $9.2 million grant renewal from the National Cancer Institute (NCI) for its continued leadership of a Specialized Programs of Research Excellence (SPORE) in Prostate Cancer.

Led by co-principal investigators Sarki Abdulkadir, MD, PhD, and Maha Hussain, MD, the multi-center consortium provides an integrated scientific environment that leverages the expertise and resources of its investigators to conduct highly translational research projects. First funded in 2001, Lurie Cancer Center’s Prostate Cancer SPORE is one of only eight in the country, and the only one in Illinois.

The Prostate Cancer SPORE brings together basic scientists, clinicians, pathologists, biostatisticians, bioinformaticians, and patient advocates to advance collaborative research projects that will be carried out by investigators at the Lurie Cancer Center, University of Chicago Comprehensive Cancer Center and NorthShore University HealthSystem. In addition, the interdisciplinary teams will design and conduct innovative clinical trials aimed at improving outcomes and overall quality of life for patients with prostate cancer. 

The SPOREs are a cornerstone of the NCI’s efforts to promote collaborative, translational cancer research. The projects supported by the grant will focus on two urgent issues in prostate cancer today, led by co-investigators with complementary basic and clinical science expertise.

Learn More About the SPORE


Annual Chung Lee Lecture was held on October 3, 2023

Annual Chung Lee Lecture was held on October 3, 2023

The lecture featured Arul Chinnaiyan, MD, PhD, of University of Michigan.  He is the director of the Michigan Center for Translational Pathology, the S.P. Hicks Endowed Professor of Pathology, Investigator at the Howard Hughes Medical Institute, and American Cancer Society Research Professor.

Prostate Cancer Clinical Trials at SPORE Sites